GL1X · GenesisL1 explorer

MolNFT v1 · #55224 · protein

Cpoga D298N in complex with P53-derived O-glcnac peptide

2YDR · O-glcnacase nagj: “Cpoga D298N in complex with P53-derived O-glcnac peptide”. X-ray diffraction, 2 ligands (NAG, CD), 7 pockets (best druggability 0.41). MolNFT v1 #55224 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2YDR
Type
protein
Length
587 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
O-glcnacase nagj; Cellular tumor antigen P53
EC
3.2.1.52
UniProt
Q0TR53, P04637
Ligands
NAG, CD
Pockets
7 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AO-glcnacase nagj (EC 3.2.1.52)protein57947% helix, 16% strandQ0TR53
PCellular tumor antigen P53protein80% helix, 0% strandP04637

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A, P
  • CD · Cadmium ion · metal · 18 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.410.8019CD
21330.410.7415empty
3780.410.7818empty
4930.390.7716empty
5850.370.7615empty

Interfaces

1 interface between chains.

  • A–P · 369 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 1 glycan (O-glycosylation).

Compared structures

  • 2YDR · CpOGA D298N in complex with p53-derived O-GlcNAc peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q0TR53 · AlphaFold monomer V2.0 prediction for O-glcnacase nagj (Q0TR53) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.